Which Paliperidone Palmitate formulation has a release duration of 3 months?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Prepare for the Schizophrenia and Psychotic Disorders Test. Enhance your learning with flashcards and multiple choice questions. Each question includes detailed explanations and important insights. Get ready to excel in your exam!

Multiple Choice

Which Paliperidone Palmitate formulation has a release duration of 3 months?

Explanation:
Long-acting injectables use depot formulations that release the medication slowly over time. Paliperidone palmitate comes in different formulations that determine how long the drug remains active in the body before next dosing. The three-month formulation is designed to release paliperidone over about three months, enabling quarterly injections. That’s why it fits a 3-month release duration. The monthly formulation releases over roughly a month, while weekly or bi-monthly schemes imply different, shorter intervals and aren’t the 3-month release profile.

Long-acting injectables use depot formulations that release the medication slowly over time. Paliperidone palmitate comes in different formulations that determine how long the drug remains active in the body before next dosing. The three-month formulation is designed to release paliperidone over about three months, enabling quarterly injections. That’s why it fits a 3-month release duration. The monthly formulation releases over roughly a month, while weekly or bi-monthly schemes imply different, shorter intervals and aren’t the 3-month release profile.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy